Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Anebulo Pharmaceuticals Inc

Current price
2.08 USD +0.01 USD (+0.48%)
Last closed 2.12 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 54 848 720 USD
Yield for 12 month -12.61 %
21.11.2021 - 28.11.2021

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas. Address: 1017 Ranch Road 620 South, Lakeway, TX, United States, 78734

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price


P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures ANEB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Operating Margin TTM
PE Ratio
Return On Assets TTM -57.9 %
PEG Ratio
Return On Equity TTM -104.28 %
Wall Street Target Price 6 USD
Revenue TTM
Book Value 0.19 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.37 USD
Diluted Eps TTM -0.37 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ANEB

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ANEB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ANEB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -6.5351
Price Book MRQ 11.613

Financials ANEB

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ANEB

For 52 weeks

1.62 USD 4.05 USD
50 Day MA 2.68 USD
Shares Short Prior Month 17 857
200 Day MA 2.61 USD
Short Ratio 1.09
Shares Short 6 194
Short Percent 0.15 %

Dynamics of changes in the value of assets




430.16 USD Microsoft Corporation +3.16 (+0.74%)
Detailed analytics

ETF funds



14.70 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) +0.1 (+0.64%)
Detailed analytics



2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics